| Literature DB >> 29916386 |
Linda A DiMeglio1, Carmella Evans-Molina2, Richard A Oram3.
Abstract
Type 1 diabetes is a chronic autoimmune disease characterised by insulin deficiency and resultant hyperglycaemia. Knowledge of type 1 diabetes has rapidly increased over the past 25 years, resulting in a broad understanding about many aspects of the disease, including its genetics, epidemiology, immune and β-cell phenotypes, and disease burden. Interventions to preserve β cells have been tested, and several methods to improve clinical disease management have been assessed. However, wide gaps still exist in our understanding of type 1 diabetes and our ability to standardise clinical care and decrease disease-associated complications and burden. This Seminar gives an overview of the current understanding of the disease and potential future directions for research and care.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29916386 PMCID: PMC6661119 DOI: 10.1016/S0140-6736(18)31320-5
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321